Novel Immunotherapeutic Approach in Gastric Cancer
Gastric cancer (GC) is suitable for immunotherapy because 80% of it display microsatellite and chromosomal instability, some mutations and DNA hypermethylation. Therefore, GC is more immunogenic. The immunotherapy with monoclonal antibodies, adoptive cell therapy and checkpoint inhibition are discus...
Guardado en:
Autores principales: | Gulubova M., Hadzhi M., Ignatova M., Chonov D., Balakan O., Aydan M., Ananiev J. |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Sciendo
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b5d19af524614ae6a6554ae15066ac52 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Immunotherapeutic Advances for NSCLC
por: Massafra M, et al.
Publicado: (2021) -
The Role of CAR-T Cells in Peritoneal Carcinomatosis from Gastric Cancer: Rationale, Experimental Work, and Clinical Applications
por: Siyuan Qian, et al.
Publicado: (2021) -
Novel Biomarkers of Gastric Adenocarcinoma: Current Research and Future Perspectives
por: Nadja Niclauss, et al.
Publicado: (2021) -
Novel CircRNAs in Hub ceRNA Axis Regulate Gastric Cancer Prognosis and Microenvironment
por: Xianghui Li, et al.
Publicado: (2021) -
Residue substitution enhances the immunogenicity of neoepitopes from gastric cancers
por: Huahui Yu, et al.
Publicado: (2021)